Literature DB >> 670082

Glycocinnamoylspermidines, a new class of antibiotics. II. Isolation, physiocochemical and biological properties of LL-BM123beta, gamma1 and gamma2.

J H Martin, M P Kunstmann, F Barbatschi, M Hertz, G A Ellestad, M Dann, G S Redin, A C Dornbush, N A Kuck.   

Abstract

LL-BM123beta, gamma1 and gamma2 are three new antibiotics produced by fermentation of an unidentified species of Nocardia. These strongly basic, water soluble compounds were isolated from the culture filtrate by CM-Sephadex ion-exchange and carbon chromatography. All three antibiotics are active against both gram-positive and gram-negative bacteria. A mixture of LL-BM123 gamma1 and gamma2 is more active than the beta component but generally less active than gentamicin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670082     DOI: 10.7164/antibiotics.31.398

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Biosynthesis of a new UDP-sugar, UDP-2-acetamido-2-deoxyxylose, in the human pathogen Bacillus cereus subspecies cytotoxis NVH 391-98.

Authors:  Xiaogang Gu; John Glushka; Sung G Lee; Maor Bar-Peled
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  Investigations of scope and mechanism of nickel-catalyzed transformations of glycosyl trichloroacetimidates to glycosyl trichloroacetamides and subsequent, atom-economical, one-step conversion to α-urea-glycosides.

Authors:  Matthew J McKay; Nathaniel H Park; Hien M Nguyen
Journal:  Chemistry       Date:  2014-06-06       Impact factor: 5.236

3.  In vitro inhibition of bacterial DNA gyrase by cinodine, a glycocinnamoylspermidine antibiotic.

Authors:  M S Osburne; W M Maiese; M Greenstein
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  Mechanism of action of cinodine, a glycocinnamoylspermidine antibiotic.

Authors:  M Greenstein; J L Speth; W M Maiese
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

Review 5.  Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

Authors:  Frédéric Collin; Shantanu Karkare; Anthony Maxwell
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.